Screening Guideline Development
Screening Guideline Development is the systematic process of creating evidence-based recommendations for the early detection of infectious cancers, distinguished from related guideline development activities by its specific focus on screening modalities, target populations, and risk stratification strategies tied to infection-related carcinogenesis.
104
Publications
7.3K
Citations
717
Authors
433
Institutions
Publications per year
2017–2026
49
Parents
104
Michael R. DeBaun, Lori C. Jordan, Allison A. King et al. · Blood Advances · 2020 · 417 citations · Full text
Medicine, Hematology, Pediatrics +17
Matthew D. Rutter, James E. East, Colin Rees et al. · Gut · 2019 · 371 citations · Full text
Familial hypercholesterolaemia: summary of NICE guidance
Anthony S. Wierzbicki, Steve E. Humphries, Rubin Minhas · BMJ · 2008 · 240 citations
Medicine, Cardiology, Genetics +14
1–5 of 104
717
3
h-index
3
h-index
3
h-index
2
h-index
2
h-index
1–5 of 717
433

Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, China
7 h-index
35 publications
1.8K citations

Centers for Disease Control and Prevention
Atlanta, United States
6 h-index
23 publications
1.6K citations

University of Toronto
Toronto, Canada
5 h-index
5 publications
334 citations
University of Washington
Seattle, United States
5 h-index
22 publications
2.1K citations
Lanzhou University
Lanzhou, China
5 h-index
6 publications
321 citations
National Cancer Institute
Bethesda, United States
4 h-index
11 publications
438 citations

The University of Sydney
Sydney, Australia
4 h-index
21 publications
468 citations
University of South Florida
Tampa, United States
4 h-index
4 publications
173 citations
1–8 of 433
Repository · 10 publications · 371 citations
10
h-index
4 publications · 574 citations
4
h-index
3 publications · 176 citations
3
h-index
3 publications · 58 citations
3
h-index
JJCO · 2 publications · 153 citations
2
h-index
1–5